Navigation Links
Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
Date:11/1/2011

consists only of sales of third-party products.

Distribution segment gross margin increased 2.1 percentage points to 17.0 percent in the third quarter 2011, as the prior year margins were impacted by a number of product launches at lower margins.

During the quarter, Anda began construction of a 234,000 square foot state-of-the-art distribution facility in Olive Branch, MS, which more closely aligns with Anda's plans for the growth of this business in the future.

Other Operating ExpensesConsolidated general and administrative expenses were $85.2 million in the third quarter 2011 compared to $163.5 million in the third quarter 2010. The third quarter of 2010 included an $89.9 million charge associated with the Company's drug pricing litigation. Excluding this prior year charge, general and administrative expenses increased $11.6 million from the third quarter 2010, primarily as a result of higher legal fees and expenses associated with Specifar's operations that were not in the prior year period. Amortization expense for the third quarter 2011 was $71.8 million, compared to $45.9 million in third quarter 2010, due to amortization of intangible assets acquired in the Specifar acquisition, amortization on newly launched products, and higher amortization rates.

2011 Financial Outlook Watson's estimates are based on actual results for the nine months ended September 30, 2011 and management's current belief about prescription trends, pricing levels, inventory levels and the anticipated timing of future product launches and events.  A number of factors are reflected in the updated forecast, and management has sought to appropriately reflect the potential impact from these factors given current visibility into the complex market environment.

-- Watson estimates total net revenue for the full year ended December 31, 2011 at approximately $4.5 billion. -- Total Global Generic segment net revenue of approximately $3.3 billion--
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
2. Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
3. Watson Confirms Daytrana(R) Patent Challenge
4. Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
5. Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
6. Watson Confirms EMBEDA(R) Patent Challenge
7. Watson Launches Generic FEMCON(R) Fe
8. Watson to Host Conference Call and Webcast to Discuss Third Quarter 2011 Earnings
9. Watson to Present at the Jefferies 2011 Global Healthcare Conference
10. Watson Confirms Amphastar Patent Lawsuit
11. Watson Pharmaceuticals Announces Approval of Amphastars Generic LOVENOX(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- Regen BioPharma, Inc. (OTCBB: RGBP) and (PINK: ... of delivering its patented (US Patent 8,263,571) gene ... a clinically approved formulation as delivery system.  The ... silencing therapeutics in which the gene silencing drug ... By utilizing a local delivery system, potential toxicities ...
(Date:8/31/2015)... , Aug. 31, 2015  Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today it has completed enrollment ... Data Review Committee (DRC) earlier this year, into ... is a first-in-class innate defense regulator (IDR) and ...
(Date:8/31/2015)... , Aug. 31, 2015  QT Vascular Ltd., together with ... together with its subsidiaries, the "Group"), a global ... of advanced therapeutic solutions for the minimally invasive ... results of the below-the-knee ("BTK") cohort of patients ... were presented on August 15, 2015 at the ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... levels were significantly higher in patients with osteosarcoma than ... Biological Trace Element Research (April 2009). Osteosarcoma, ... young adults.Randhu and colleagues measured serum fluoride levels in ... one had osteosarcoma, group two had non-osteosarcoma bone tumors, ...
... U.S. Agency for International Development (USAID) is convening a ... Ethiopia, in a regional exercise that will kick off ... The three-day exercise seeks to advance global capacity ... a pandemic. As recently emphasized by outbreaks of swine ...
Cached Medicine Technology:Another Study Links Fluoride to Bone Cancer 2USAID Cooperates in Pandemic Preparedness Initiative 2USAID Cooperates in Pandemic Preparedness Initiative 3
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a social well-being company ... app, Walkadoo , by including an in-app step tracker. , Walkadoo is a ... walking habits. Rather than broadly assign every Walkadoo member 10,000 steps a day (as ...
(Date:8/31/2015)... ... August 31, 2015 , ... The ... the use of health IT to create efficiencies in healthcare information exchange, announces ... . Taking place at the Hyatt Regency Reston in Reston, Va. from October ...
(Date:8/31/2015)... ... August 31, 2015 , ... It’s a lot like ... director of GreenFields of Geneva. During his first days on the job, he’s run ... nice seeing them, and I like knowing that they’re living in such a wonderful ...
(Date:8/31/2015)... ... August 31, 2015 , ... The ... Talent Management Division , a department devoted to helping organizations identify and keep ... goes beyond selection, and The Brooks Group believes in offering a solution that ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Commerce Exchange and Organization Supporting Business Owners and provided a tour of their ... Georgia, represents the success possible to international companies expanding business in the U.S. ...
Breaking Medicine News(10 mins):Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3Health News:PartnerTech Supports Economic Growth as Host 2
... HealthDay Reporter , TUESDAY, Oct. 25 (HealthDay News) ... cantaloupes produced at a Colorado farm has reached 28, with ... late Tuesday. Officials said last week that the outbreak ... farm. Inspections on Sept. 22 and 23 ...
... potential leukemia therapy targets only cancer cells, while leaving ... cancer cells and healthy cells, causing significant side effects, ... This research is being presented at the 2011 ... Exposition in Washington, D.C., Oct. 23 27. ...
... both men and women, yet men remain underrepresented in research. A ... has found that the medical impact of the disorder is ... research has shown that the number of men seeking treatment is ... is closely linked to obesity and excessive weight gain as well ...
... high proportion of dense breast tissue, as seen with a ... But the role of non-dense fat tissue in the breast ... access journal Breast Cancer Research separates the breast ... shows that large areas of either are independently associated with ...
... TUESDAY, Oct. 25 (HealthDay News) -- Men with a history ... for lung cancer could benefit from a simultaneous check for ... estimated that smoking will cause more than 8 million deaths ... addition to cardiovascular disease and cancer, COPD is a major ...
... activity and cancer prevention, treatment recovery and survivorship have ... component in the treatment of a disease that claims ... to the American Cancer Society,s Global Facts and Figures. ... and Cancer, Dr. Kerry Courneya, is one of the ...
Cached Medicine News:Health News:Death Toll From Listeria Outbreak Hits 28 2Health News:Death Toll From Listeria Outbreak Hits 28 3Health News:Study shows why underrepresented men should be included in binge eating research 2Health News:CT Scans May Pick Up COPD Early in Smokers 2Health News:CT Scans May Pick Up COPD Early in Smokers 3Health News:Canada Research Chair renewal for Kerry Courneya 2Health News:Canada Research Chair renewal for Kerry Courneya 3
The Genesis Camera meets the needs of those with specific requirements that cannot be met by a conventional 'chinrest' type camera....
Eye Q PRO is the optimum choice for ophthalmologists and clinicians specializing in advanced pathology and research....
Auto Lensmeter LM-970...
... designed to eliminate the subjective nature of ... providing repeatable, objective measurements every time. The ... icon-based operating system ensure fast and simple ... optimal lens positioning and, in auto mode, ...
Medicine Products: